ArticleCNS neuroscience & therapeutics2022

Telitacicept following plasma exchange in the treatment of subjects with recurrent neuromyelitis optica spectrum disorders: A single-center, single-arm, open-label study.

Jie Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.